ARC Group Worldwide, Inc. (ARCW) stock prices updated...
 

ARC Group Worldwide, Inc. stock price

ARC Group Worldwide, Inc. latest news:


  • 01/16/2018 15:33:00

    Exelixis, Ipsen report positive cancer-study results

    Exelixis Inc. and Ipsen said Tuesday that a cancer drug achieved its target in a late-stage study and will be submitted to the Food and Drug Administration before the end of the quarter. The companies said that its cabozantinib drug helped patients with advanced hepatocellular carcinoma survive a median 2.2 months longer than patients who received placebos in a phase 3 trial. "Given the worldwide prevalence of advanced hepatocellular carcinoma, there is a continued urgency to bring new treatment options to this patient population," Exelixis Chief Medical Officer Gisela Schwab said in Tuesday's announcement. "We look forward to submitting our supplemental New Drug Application to the FDA for cabozantinib in the first quarter of 2018." The companies plan to present the results at a symposium in San Francisco later this week, and will hold a webcast meant for investors Friday evening. Exelixis shares were halted ahead of the announcement, and gained about 2% in after-hours action after they began trading again at 5:30 p.m. Eastern time.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/30/2017 14:03:50

    BRIEF-Arc Group Worldwide Names Brian Knaley As CFO

    * ARC GROUP WORLDWIDE INC - ANNOUNCED APPOINTMENT OF R. BRIAN KNALEY AS COMPANY'S NEW CHIEF FINANCIAL OFFICER

  • 11/03/2017 13:20:29

    BRIEF-Stifel, Nicolaus & Co Inc reported passive stake of 5.08 pct in Arc Group Worldwide

    Arc Group Worldwide Inc(ARCW): * Stifel, Nicolaus & Company Inc reported passive stake of 5.08 percent in Arc Group Worldwide Inc (ARCW) as on October 31, 2017 - SEC filing‍​‍​ Source text Further company coverage:

  • More trends:

    ARCA biopharma, Inc.ABIO | Arcadia Biosciences, Inc.RKDA | ArcBest CorporationARCB | Arch Capital Group Ltd.ACGL | Arctic Cat Inc.ACAT | Ardelyx, Inc.ARDX | Arena Pharmaceuticals, Inc.ARNA | Ares Capital CorporationARCC | Argo Group International Holdings, Ltd.AGII | Argo Group International Holdings, Ltd.AGIIL |